Report cover image

Estrogen Blockers Market

Publisher Coherent Market Insights
Published Jul 12, 2023
Length 150 Pages
SKU # CMI18107885

Description

Estrogen Blockers Market, By Product Type (Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors, Estrogen Receptor Downregulators (ERDs), Others), By End User (Hospitals and Clinics, Research Institutes, Individuals), By Application (Breast Cancer Treatment, Hormone Replacement Therapy (HRT), Infertility Treatment, Post-Menopausal Osteoporosis, Others), By Distribution Channel (Hospitals and Specialty Clinics, Retail Pharmacies, Online Stores, Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Estrogen blockers are medicines that are used by FTM (Female to Male) individuals as part of their hormone replacement therapy (HRT) to suppress the effects of estrogen in the body. They can also help to promote the development of male secondary sexual characteristics. There are many different types of Estrogen Blockers available, and some are more effective than others.

Estrogen blockers can be taken in the form of tablets or injections. They are usually prescribed as part of a larger HRT treatment plan and are generally well tolerated by individuals who take them. For the most part, a hospital stay is not required when taking these medications, and they can often be given at home.

Market Dynamics

Estrogen blockers are largely used to treat hormone-related diseases like polycystic ovary syndrome (PCOS), endometriosis, and breast cancer. The demand for estrogen blockers rises as the prevalence of these illnesses rises internationally, fueling market expansion.

Like any drug, estrogen blockers have potential risks and adverse effects. Hot flashes, mood swings, joint discomfort, and increases in cholesterol levels are examples of typical side effects. In some circumstances, long-term usage of estrogen blockers may raise the risk of cardiovascular issues and bone loss. Patients' compliance with and acceptance of estrogen blockers may be impacted by safety worries and possible side effects.

Key features of the study:
  • This report provides in-depth analysis of the global estrogen blockers market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global estrogen blockers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer Inc., Novartis AG, AstraZeneca PLC, Eli Lilly and Company, Merck & Co., Inc., Bristol Myers Squibb Company, Johnson & Johnson, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global estrogen blockers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global estrogen blockers market
Detailed Segmentation:
  • Global Estrogen Blockers Market, By Product Type:
  • Selective Estrogen Receptor Modulators (SERMs)
  • Aromatase Inhibitors
  • Estrogen Receptor Downregulators (ERDs)
  • Others
  • Global Estrogen Blockers Market, By Application:
  • Breast Cancer Treatment
  • Hormone Replacement Therapy (HRT)
  • Infertility Treatment
  • Post-Menopausal Osteoporosis
  • Others
  • Global Estrogen Blockers Market, By Distribution Channel:
  • Hospitals and Specialty Clinics
  • Retail Pharmacies
  • Online Stores
  • Others
  • Global Estrogen Blockers Market, By End User:
  • Hospitals and Clinics
  • Research Institutes
  • Individuals
  • Global Estrogen Blockers Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Company Profiles:
  • Pfizer Inc.
  • Novartis AG
  • AstraZeneca PLC
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Bristol Myers Squibb Company
  • Johnson & Johnson
  • Sanofi S.A.
  • AbbVie Inc.
  • GlaxoSmithKline plc

Table of Contents

150 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing Prevalence of Hormone-related Disorders
Restraints
Side Effects and Safety Concerns
Opportunities
Expansion of Indications
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Estrogen Blockers Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Estrogen Blockers Market , By Product Type, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Selective Estrogen Receptor Modulators (SERMs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Aromatase Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Estrogen Receptor Downregulators (ERDs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Estrogen Blockers Market , By Application, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Breast Cancer Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Hormone Replacement Therapy (HRT)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Infertility Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Post-Menopausal Osteoporosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
7. Global Estrogen Blockers Market , By Distribution Channel, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Hospitals and Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Online Stores
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Global Estrogen Blockers Market , By End User, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Individuals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
9. Global Estrogen Blockers Market , By Region, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2018 –2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
10. Competitive Landscape
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
AstraZeneca PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Eli Lilly and Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Bristol Myers Squibb Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Sanofi S.A.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
AbbVie Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GlaxoSmithKline plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
11. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Estrogen Blockers Market” - Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us